IMV - IMV Inc. (IMV) CEO Andrew Hall on Q1 2022 Results - Earnings Call Transcript

IMV Inc. (IMV) Q1 2022 Earnings Conference Call May 13, 2022, 8:00 AM ET Company Participants Andrew Hall – Chief Executive Officer Jeremy Graff – Chief Medical Officer Brittany Davison – Senior Vice President, Finance Joy Bessenger – Senior Vice President, Investor Relations & Corporate Strategy Conference Call Participants Joseph Pantginis – H.C. Wainwright & Co. Nick Abbott – Wells Fargo Securities Brandon Folkes – Cantor Fitzgerald Paul Stewardson – iA Capital Markets Presentation Joy Bessenger Good morning, everyone. I am Joy Besenger, Head of Investor Relations and Corporate strategies for IMV and I'm pleased to welcome you all to our First Quarter 2022 Clinical and Operational Update Conference Call. I'm joined today by Andrew Hall, our CEO, Dr. Jeremy Graff, our CSO and [Indiscernible]. During this call, we will discuss our business outlook and make forward-looking statements. Any forward-looking statements made today are pursuant to [Indiscernible] Safe Harbor provisions

For further details see:

IMV Inc. (IMV) CEO Andrew Hall on Q1 2022 Results - Earnings Call Transcript